CPHRF News and Press, Companhia Siderurgica Paulista Nova Cosipa From 05/08/20

Cipher Pharmaceuticals ( OTC:CPHRF ): Q1 GAAP EPS of $0.10 beats by $0.05 . Revenue of $5.9M (+15.7% Y/Y) beats by $1.06M . Press Release More news on: Cipher Pharmaceuticals Inc., Earnings news and commentary, ,

Cipher Pharmaceuticals Reports First Quarter 2020 Financial Results Canada NewsWire OAKVILLE, ON, May 7, 2020 Earnings per common share increases to $0.10 ( $0.13 in Canadian Dollars 1 ) OAKVILLE, ON , May 7, 2020 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) (" ...

Cipher Pharmaceuticals Schedules Q1 2020 Earnings Release and Conference Call Canada NewsWire OAKVILLE, ON, April 27, 2020 OAKVILLE, ON , April 27, 2020 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) (" Cipher " or "the Company ") today announced it will release its Q1 20...

Cipher Pharmaceuticals Receives Positive Ruling on Binding Arbitration with Upsher-Smith Laboratories Canada NewsWire OAKVILLE, ON, April 20, 2020 OAKVILLE, ON , April 20, 2020 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) (" Cipher " or " the Company ") today announ...

Cipher Pharmaceuticals Inc. (CPHRF) Q4 2019 Earnings Conference Call March 26, 2020, 08:30 AM ET Company Participants Craig Mull - Interim CEO Nadine Jutlah - Interim CFO Conference Call Participants Andre Uddin - Mackie Research Capital Doug Loe - Echelon Wealth Partners ...

Cipher Pharmaceuticals ( OTC:CPHRF ): Q4 GAAP EPS of $0.10 beats by $0.06 . More news on: Cipher Pharmaceuticals Inc., Earnings news and commentary, , Read more ...

Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results Canada NewsWire OAKVILLE, ON, March 25, 2020 Adjusted EBITDA reaches $4.2 million and Net income increases to $2.6 million in the fourth quarter OAKVILLE, ON , March 25, 2020 /CNW/ ...

Notice of Cipher Pharmaceuticals Q4 2019 Conference Call Canada NewsWire OAKVILLE, ON, Feb. 20, 2020 OAKVILLE, ON , Feb. 20, 2020 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) ("Cipher" or "the Company") today announced the details of its Q4 2020 financial results confere...

Cipher Pharmaceuticals Provides Update on Absorica Brand Extension Program with Sun Pharmaceutical Canada NewsWire OAKVILLE, ON, Feb. 6, 2020 OAKVILLE, ON , Feb. 6, 2020 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) ("Cipher" or "the Company") is pleased to announce ...

Cipher Pharmaceuticals ( OTC:CPHRF ) reports that Bausch Health Companies (NYSE: BHC ) has notified it that it intends to terminate its license agreement for constipation med Trulance (plecanatide) due to an undisclosed breach of certain provisions of the contract. More news on: Cipher P...